Related content

ERGIC3, which is regulated by miR‐203a, is a potential biomarker for non‐small cell lung cancer

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1463-1473 (11)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients

By Jiang Min   Zhang Peng   Hu Guozhu   Xiao Zuke   Xu Fanghua   Zhong Ting   Huang Fang   Kuang Haibin   Zhang Wei  

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 67-75 (9)

Springer Publishing Company

Access to resources Recommend Favorite

Growth inhibitory effects of miR‐221 and miR‐222 in non‐small cell lung cancer cells

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 551-564 (14)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer

By Xu Chunhua   Hao Keke   Yu Like   Zhang Xiuwei  

Biomarkers, Vol. 19, Iss. 4, 2014-06 ,pp. : 287-290 (4)

Informa Healthcare

Access to resources Recommend Favorite

Demethylation of miR-9-3 and miR-193a Genes Suppresses Proliferation and Promotes Apoptosis in Non-Small Cell Lung Cancer Cell Lines

By  

Cellular Physiology and Biochemistry, Vol. 32, Iss. 6, 2013-12 ,pp. : 1707-1719 (13)

Karger

Access to resources Recommend Favorite